期刊文献+

载异烟肼利福平聚乳酸纳米粒的制备及体外释药 被引量:5

Preparation and in vitro release of polylactic acid nanoparticles loaded with isoniazid and rifampicin
暂未订购
导出
摘要 背景:微载体药物因具有靶向性、控释性、稳定性、更好的安全性备受关注。目的:观察载异烟肼利福平两种抗结核药于同一聚乳酸纳米粒的给药系统及体外释放特性。方法:采用改良的自乳化二元溶剂扩散法制备载异烟肼和利福平纳米粒,亚微粒径分析仪测定纳米粒粒径及分布,透射电镜观察其形态;高效液相色谱仪建立测定异烟肼、利福平的载药量和包封率;以磷酸盐缓冲液为释放介质,观察载异烟肼和利福平纳米粒的体外释药特性。结果与结论:载利福平和异烟肼纳米粒表面完整光滑,无明显粘连现象,纳米粒均匀度好。亚微粒径分析仪测定纳米粒平均粒径80.4nm。异烟肼载药量为(15.95±1.34)%,包封率为(5.01±0.17)%;利福平载药量为(4.66±0.97)%,包封率为(4.05±0.18)%。体外释药结果显示纳米粒的体外释药过程较平稳。突释期纳米粒中异烟肼释放度为15.22%,到3d累积释放度可达95.6%;利福平释放度为9.26%,到3d累积释放度可达90.3%。提示采用改良的自乳化二元溶剂扩散法制备载异烟肼和利福平纳米粒,所得载药纳米粒的粒径小且较均匀。纳米粒体外释药过程较平稳,无明显突释现象。 BACKGROUND: Micro-carrier drugs receive much concern based on their targeting, controlled-release, stability and good safety. OBJECTIVE: To study release characteristics of polylactic acid nanoparticles loaded with isoniazid and rifampicin (INH-RFP-PLA-NPs) in vitro. METHODS: INH-RFP-PLA-NPs were prepared with pusing modified spontaneous emulsification solvent diffusion method. The submicron particle size analyzer was used to detect the nanoparticle size and its distribution of INH-RFP-PLA-NPs. Observation of the morphology of INH-RFP-PLA-NPs was performed with transmission electron microscope. High performance liquid chromatography was used to detect drug loading and encapsulation efficiency. Phosphate buffer solution was used as a release medium to study the in vitro release characteristics of INH-RFP-PLA-NPs. RESULTS AND CONCLUSION: The INH-RFP-PLA-NPs were smooth and uniform without obvious adhesion. The submicron particle size analyzer showed the mean diameter was 80.4 nm. The drug loading and entrapment efficiency of isoniazid were (15.95±1.34)% and (5.01±0.17)% resectively, and those of rifampicin were (4.66±0.97)% and (4.05±0.18)% respectively. Release in vitro of INH-RFP-PLA-NPs was stable. Release rate of isoniazid was 15.22% in burst release phrase, and rose to 95.6% after 3 days; release rate of rifampicin was 9.26% and rose to 90.3% after 3 days. INH-RFP-PLA-NPs prepared by modified spontaneous binary solvent diffusion method have small and uniform mean diameter. Release in vitro of INH-RFP-PLA-NPs is stable without obvious burst release.
出处 《中国组织工程研究》 CAS CSCD 2012年第16期2909-2912,共4页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金资助项目(30960391) 宁夏自然科学基金项目(NZ09127)~~
  • 相关文献

参考文献21

  • 1Meijer DK,Jansen RW,Molema G. Drug targeting systems for antiviral agents:options and limitations[J].Antiviral Research,1992,(3-4):215-258.
  • 2Murakami H,Kobayashi M,Takeuchi H. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method[J].International Journal of Pharmaceutics,1999,(02):143-152.
  • 3Sakagami M. In vivo,in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery[J].Advanced Drug Delivery Reviews,2006,(9-10):1030-1060.
  • 4Gaspar MM,Cruz A,Penha AF. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis[J].International Journal of Antimicrobial Agents,2008,(01):37-45.
  • 5El-Ridy MS,Mostafa DM,Shehab A. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis[J].International Journal of Pharmaceutics,2007,(1-2):82-88.
  • 6Shafiq S,Shakeel F. Effect of Labrasol on self-nanoemulsification efficiency of ramipril nanoemulsion[J].Die Pharmazie,2009,(12):812-817.
  • 7Ahmed M,Ramadan W,Rambhu D. Potential of nanoemulsions for intravenous delivery of rifampicin[J].Die Pharmazie,2008,(11):806-811.
  • 8Scholes PD,Coombes AG,Iium L. The preparation of sub-500nm poly(lactic acid) nanoparticles perared by double emulsion methods[J].Journal of Controlled Release,1993,(1-2):145-153.
  • 9Song CX,Labhasetwar V. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery[J].Journal of Controlled Release,1997,(2-3):197-212.
  • 10Niwa T,Takeuchi H,Hino T. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method[J].Journal of Pharmaceutical Sciences,1994,(05):727-732.

二级参考文献30

  • 1[1]Anderson JM.Perspectives on the in vivo responses of biodegradable polymers[A].In:Biomedical applications of synthetic biodegradable polymers[M].Boca Raton:CRC Press,FL,1995.223-233.
  • 2[2]Okada H,Toguchi H.Biodegradable microspheres in drug delivery[J].Crit Rev Therap,1995,12∶1-99.
  • 3[3]Li S,Vert M.Biodegradation of aliphatic polyesters[A],In:Scott G,Gilead D eds.Degradable Polymers[M].London:Chapman and Hall.1995.43-87.
  • 4[4]Schakenraad JM,Hardon MJ,Feijen J,et al.Enzymatic activity toward poly(L-Lactic acid)implants[J].J Biomed Mater Res,1990,24∶529-545.
  • 5[5]Bodmeier R,Chen H.Effect of the addition of low molecular weight poly(dl-lactide)on drug release from biodegradable poly(dl-lactide) drug delivery system[J].Int J Pharm,1989,51∶1-8.
  • 6[6]Vert M,Mauduit J,Li S.Biodegradation of PLA/GA polymers: increasing complexity[J].Biomaterials,1994,15∶1209-1213.
  • 7[7]Grizzi I,Garreau H,Li S,et al.Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence[J].Biomaterials,1995,16∶305-311.
  • 8[8]Spenlehauer G,Vert M,Benoit JP,et al.In vitro and in vivo degradation of poly(DL-lactide/glycolide) type microspheres made by solvent evaporation method[J].Biomaterials,1989,10∶557-563.
  • 9[9]Beck LR,Cowsar DR,Lewis DH.Systemic and local delivery of contraceptive steroids using biodegradable microspheres[A].In:Hafez ESE, WAA Van Os eds.Biodegradables and delivery systems for contraception[M].MTP Press Limited,1980. 63-82.
  • 10[10]Tice TR,Lewis DH,Dunn RL,et al.Biodegradation of microspheres and biomedical devices prepared with resorbable polyesters[A].In:9th international symposium on controlled release of bioactive materials[C].The Controlled Release Society,Inc,1982.21-25.

共引文献26

同被引文献108

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部